Track the Lftd Partners INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Retail & Commerce sector, Lftd Partners INC. has published 12 insider filings. Market capitalisation: €2.8m. The latest transaction was filed on 21 November 2023 (Acquisition). Among the most active insiders: JACOBS GERARD M.. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
LFTD Partners Inc. (ticker: LIFD) is a United States-based company whose shares are quoted on the OTCQB market rather than NYSE/NASDAQ at this stage, although it remains a relevant name for U.S. small-cap and event-driven investors. The company is headquartered in Jacksonville, Florida, United States, and its current corporate identity reflects a strategic repositioning completed in 2021, when it changed its name from Acquired Sales Corp. toward a consumer-brand model focused on alternative lifestyle products. ([lftdpartners.com](https://www.lftdpartners.com/investors)) The group’s core operating asset is Lifted Made, a wholly owned subsidiary based in Kenosha, Wisconsin. Lifted manufactures and sells hemp-derived and other psychoactive consumer products under brands such as Urb Finest Flowers, Highlandia, and Mielos. Recent SEC filings indicate that the portfolio spans hemp-derived beverages, hemp-free wellness gummies, disposable vape products, and other branded items associated with cannabinoids and functional ingredients such as kava and ashwagandha. This gives LFTD a business model that blends brand ownership, manufacturing, and commercial distribution, while also allowing the company to act as a manufacturing and marketing partner for third-party brands. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000803/lftp_10q.htm?utm_source=openai)) From a competitive standpoint, LFTD operates in a fragmented and highly regulated niche market where success depends on product innovation, regulatory adaptability, speed of commercialization, and brand differentiation. It is not a dominant large-cap operator; rather, it is a specialized player seeking to build value in emerging consumer categories that often have fewer established national leaders. The company also holds minority interests in certain CBD beverage and spirits businesses, which suggests a broader portfolio approach and a willingness to participate in adjacent consumer channels. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001391135/000109690624000671/lsfp_10k.htm?utm_source=openai)) Recent corporate developments include the filing of the 2024 Form 10-K and subsequent 2025 quarterly reports, as well as disclosure of goodwill impairment charges in the latest SEC filings, which is an important signal for analysts assessing asset quality and profitability. For investors in France, Belgium, and Switzerland, LIFD should therefore be viewed as a speculative U.S. micro/small-cap consumer company with a differentiated brand platform, but also with elevated execution, regulatory, and balance-sheet risk. ([lftdpartners.com](https://www.lftdpartners.com/investors))